| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/01/2004 | US6743781 Glycerolipid compounds useful for the transfer of an active substance into a target cell |
| 06/01/2004 | US6743780 Repressor titration for maintenance of a plasmid useful in gene therapy |
| 06/01/2004 | US6743779 Methods for delivering compounds into a cell |
| 06/01/2004 | US6743778 Apo-AI/AII peptide derivatives |
| 06/01/2004 | US6743774 Tribonectins |
| 06/01/2004 | US6743631 Non-primate mammalian cell lines having no endogenous retroviral sequences for packaging; envelope proteins; gag/pol genes |
| 06/01/2004 | US6743627 Using polyamide nucleic acid oligomers to engender a biological response |
| 06/01/2004 | US6743625 Death domain containing receptor 5 |
| 06/01/2004 | US6743623 Viral recombinant vectors for expression in muscle cells |
| 06/01/2004 | US6743622 Homologous recombination antibody expression system for murine cells |
| 06/01/2004 | US6743621 Human proteases and polynucleotides encoding the same |
| 06/01/2004 | US6743620 Comprises transgenic gag/pol gene expression systems; recombinases; antibiotic resistance; envelope proteins; vesicular stomatitis virus g-protein |
| 06/01/2004 | US6743617 Can be used against bacterial infections, as digestive enzyme in some mollusks which live on bacteria, anti-tumor agent |
| 06/01/2004 | US6743616 Highly productive alpha-amylases |
| 06/01/2004 | US6743611 For encoding clover yellow vein virus nuclear inclusion-a proteins; proteases; aminopeptidases |
| 06/01/2004 | US6743607 Production of complex carbohydrates |
| 06/01/2004 | US6743606 Synthesis of a glucosyl diacylglycerol, a sterolglucoside, a glucocerebroside, an alkyl-beta-d-glucopyranoside, or a phosphoglucolipid in a cell by the use of a processive lipid glucosyl transferase |
| 06/01/2004 | US6743605 Resulting in decreased thermodynamic stability to complementary sequences |
| 06/01/2004 | US6743604 Polypeptides binding human il-13 and/or il-4 cytokines used in medicine, diagnosis and screening for agonists/ antagonists of il-13/il-4 |
| 06/01/2004 | US6743603 Tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 06/01/2004 | US6743584 Molecular-biological marker for analytical electron microscopy |
| 06/01/2004 | US6743582 Detecting preferential nucleotide sequences in sample; obtain sample containing nucleotide sequences, incubate with primer, amplify, hybridize signal probe, detect signal |
| 06/01/2004 | US6743577 Methods of using cyanovirins to inhibit viral infection |
| 06/01/2004 | US6743444 Method of making microencapsulated DNA for vaccination and gene therapy |
| 06/01/2004 | US6743431 Capsular polysaccharide adhesin antigen, preparation, purification and use |
| 06/01/2004 | US6743428 Angiogenesis inhibitor |
| 06/01/2004 | US6743422 Protein selected from group consisting of residues 66 through 208 of specified amino acid sequence and residues 66 through 208 of same sequence and n-terminal methionine; stimulates production of epithelial cells |
| 06/01/2004 | CA2170605C Mutants of the rb and p53 genes and uses thereof |
| 06/01/2004 | CA2165934C A brassica sp. polygalacturonase gene promoter |
| 06/01/2004 | CA2078571C Bacillus thuringiensis cryiiic gene and protein toxic to coleopteran insects |
| 06/01/2004 | CA2063176C Process for the preparation of glutarylacylase in large quantities |
| 06/01/2004 | CA2037677C Process for production of exogenous gene or its product in plant cells |
| 06/01/2004 | CA2034034C Process for the production of antibodies |
| 05/29/2004 | CA2451584A1 Modified cdna factor viii and its derivatives |
| 05/28/2004 | CA2413175A1 Sequence specific dna recombination in eukaryotic cells |
| 05/27/2004 | WO2004044553A2 Lepidoptera voltage-gated calcium channels |
| 05/27/2004 | WO2004044244A1 Method of detecting human serotonin 5-ht4 receptor gene type in nucleic acid sample |
| 05/27/2004 | WO2004044243A1 Method of amplifying nucleic acid and apparatus tehrefor |
| 05/27/2004 | WO2004044226A2 Induction of cellular senescence by cdk4 disruption for tumor supression and regression |
| 05/27/2004 | WO2004044221A2 High throughput automatic nucleic acid isolation and quantitation methods |
| 05/27/2004 | WO2004044217A2 Dna sequences from tcd genomic region of photorhabdus luminescens |
| 05/27/2004 | WO2004044211A1 Cells overexpressing lipoyl-protein ligase b-gene for fermentative production of r-alpha-liponic acid |
| 05/27/2004 | WO2004044208A2 Food flours with specific technological characteristics and low allergenicity |
| 05/27/2004 | WO2004044207A1 Plant stress tolerance genes, and uses therefor |
| 05/27/2004 | WO2004044206A1 Plasmids expressing human insulin and the preparation method for human insuling thereby |
| 05/27/2004 | WO2004044205A1 Plant seed-specific expression promoter derived from sesame and seed-specific expression vector comprising the promoter |
| 05/27/2004 | WO2004044204A2 Variable fragments of single-chain camelide antibodies and uses thereof for diagnosing and treating various pathologies |
| 05/27/2004 | WO2004044202A1 Method for the gene regulation at both transcription and post-transcription levels |
| 05/27/2004 | WO2004044201A1 Signaling proteins participating in immunopotentiation by virus-origin double-stranded rna and endotoxin and genes thereof |
| 05/27/2004 | WO2004044200A1 Gene elevating cereal yield and utilization thereof |
| 05/27/2004 | WO2004044197A1 Knock-in mouse prostate cancer model |
| 05/27/2004 | WO2004044195A2 Polynucleotides encoding agmatine coumaroyltransferase (act) and uses thereof |
| 05/27/2004 | WO2004044193A1 Modified sarcosine oxidase, process for producing the same and reagent composition using the same |
| 05/27/2004 | WO2004044190A2 Zymogen-like protein c polypeptides |
| 05/27/2004 | WO2004044185A1 Recombinant vitellogenin enriched feed |
| 05/27/2004 | WO2004044184A1 Biological carriers for the delivery of proteins or peptides |
| 05/27/2004 | WO2004044181A2 Antisense modulation of apolipoprotein b expression |
| 05/27/2004 | WO2004044177A2 Expression profiling based on histocultures |
| 05/27/2004 | WO2004044173A2 Cis-prenyltransferases from the rubber-producing plants russian dandelion (taraxacum kok-saghyz) and sunflower (helianthus annus) |
| 05/27/2004 | WO2004044167A2 Expression, purification and uses of a plasmodium falciparum liver stage antigen 1 polypeptide |
| 05/27/2004 | WO2004044164A2 Method for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044163A2 Methods for identifying risk of melanoma and treatments thereof |
| 05/27/2004 | WO2004044161A2 Expression of foreign sequences in plants using trans-activation system |
| 05/27/2004 | WO2004044160A2 Muc1 interference rna compositions and methods derived therefrom |
| 05/27/2004 | WO2004044159A2 Receptors and membrane-associated proteins |
| 05/27/2004 | WO2004044157A2 Gp64-pseudotyped vectors and uses thereof |
| 05/27/2004 | WO2004044156A2 Transgenic ungulates having reduced prion protein activity and uses thereof |
| 05/27/2004 | WO2004044151A2 Recombinase mediated transcription |
| 05/27/2004 | WO2004044150A2 Systems for gene targeting and producing stable genomic transgen e insertions |
| 05/27/2004 | WO2004044147A2 Modified dendritic cells |
| 05/27/2004 | WO2004044145A2 Compositions and methods for enhancing disease resistance in fish |
| 05/27/2004 | WO2004044143A2 Tps plant gene constructs and transformants |
| 05/27/2004 | WO2004044141A2 Conjugated oligomeric compounds and their use in gene modulation |
| 05/27/2004 | WO2004044140A2 2’-substituted oligomeric compounds and compositions for use in gene modulations |
| 05/27/2004 | WO2004044139A2 Modified oligonucleotides for use in rna interference |
| 05/27/2004 | WO2004044138A2 Chimeric oligomeric compounds and their use in gene modulation |
| 05/27/2004 | WO2004044137A2 Modified oligomeric compounds and compositions for use in gene modulation |
| 05/27/2004 | WO2004044136A2 Compositions comprising alternating 2’-modified nucleosides for use in gene modulation |
| 05/27/2004 | WO2004044135A2 Structural motifs and oligomeric compounds and their use in gene modulation |
| 05/27/2004 | WO2004044134A2 Phosphorous-linked oligomeric compounds and their use in gene modulation |
| 05/27/2004 | WO2004044133A2 Modified oligonucleotides for use in rna interference |
| 05/27/2004 | WO2004044132A2 Modified oligonucleotides for use in rna interference |
| 05/27/2004 | WO2004044131A2 Cross-linked oligomeric compounds and their use in gene modulation |
| 05/27/2004 | WO2004044123A2 Bioinformatically detectable group of novel regulatory genes and uses thereof |
| 05/27/2004 | WO2004044008A1 Dna/rna transduction technology and its clinical and basic applications |
| 05/27/2004 | WO2004044005A1 Kit for assaying human low-molecular weight cd14 and antibody |
| 05/27/2004 | WO2004044004A2 T cell receptor display |
| 05/27/2004 | WO2004044003A2 Use of edg2 receptor in an animal model of heart failure |
| 05/27/2004 | WO2004043996A2 Ligands |
| 05/27/2004 | WO2004043981A2 Nucleic acids and proteins with thioredoxin reductase activity |
| 05/27/2004 | WO2004043979A2 Sugar surrogate-containing oligomeric compounds and compositions for use in gene modulation |
| 05/27/2004 | WO2004043978A2 2'-methoxy substituted oligomeric compounds and compositions for use in gene modulations |
| 05/27/2004 | WO2004043977A2 2’-fluoro substituted oligomeric compounds and compositions for use in gene modulations |
| 05/27/2004 | WO2004043970A1 Novel lipophilic compounds and uses thereof |
| 05/27/2004 | WO2004043886A2 Production of pharmaceutically active proteins in sprouted seedlings |
| 05/27/2004 | WO2004043885A2 Benzoate inducible promoters |
| 05/27/2004 | WO2004043495A1 Delivery agent, method of delivering a target substance to cells, method for producing delivery agent, composition for producing delivery agent, and kit for producing delivery agent |
| 05/27/2004 | WO2004043488A1 Malaria vaccine |
| 05/27/2004 | WO2004043468A1 Screening method |
| 05/27/2004 | WO2004043407A2 Methods and products for treating staphylococcal infections |